Auditory Brainstem Evoked Responses In Migraine Patients

10.5580/24fb ◽  
2009 ◽  
Vol 10 (2) ◽  
Keyword(s):  
Auditory Brainstem ◽  
Evoked Responses ◽  
Auditory Brainstem Evoked Responses

Impaired Auditory Brainstem-evoked Responses in Insulin-dependent Diabetic Subjects

Diabetes ◽  
1984 ◽  
Vol 33 (11) ◽  
pp. 1085-1089 ◽  
Author(s):  
D. Fedele ◽  
A. Martini ◽  
C. Cardone ◽  
F. Comacchio ◽  
F. Bellavere ◽  
...  
Keyword(s):  
Auditory Brainstem ◽  
Evoked Responses ◽  
Insulin Dependent ◽  
Insulin Dependent Diabetic ◽  
Auditory Brainstem Evoked Responses

Auditory brainstem evoked responses (ABER) in children with autistic behaviour

1984 ◽  
Vol 12 (2) ◽  
pp. 193-194 ◽  
Author(s):  
B. Garreau ◽  
S. Roux ◽  
P. Tanguay ◽  
N. Bruneau ◽  
G. Lelord
Keyword(s):  
Auditory Brainstem ◽  
Evoked Responses ◽  
Autistic Behaviour ◽  
Auditory Brainstem Evoked Responses

Auditory brainstem evoked responses in autistic children

1980 ◽  
Vol 10 (2) ◽  
pp. 215-225 ◽  
Author(s):  
Stuart M. Rosenblum ◽  
Joel R. Arick ◽  
David A. Krug ◽  
E. Gene Stubbs ◽  
Norton B. Young ◽  
...  
Keyword(s):  
Auditory Brainstem ◽  
Evoked Responses ◽  
Autistic Children ◽  
Auditory Brainstem Evoked Responses

scholarly journals A study of effect of aminoglycoside therapy on auditory brainstem evoked responses in preterm and term neonates

2020 ◽  
Vol 7 (8) ◽  
pp. 1741
Author(s):  
Mukesh Kumar ◽  
Manish Parakh ◽  
D. R. Dabi ◽  
B. D. Gupta
Keyword(s):  
Auditory Brainstem ◽  
Preterm Neonates ◽  
Control Group ◽  
Final Conclusion ◽  
Study Group ◽  
Evoked Responses ◽  
Term Neonates ◽  
Aminoglycoside Therapy ◽  
Significant Difference ◽  
Auditory Brainstem Evoked Responses

Background: Aminoglycosides are widely used drugs in neonates with associated ototoxic side effects, that can be diagnosed with auditory brainstem evoked responses, which is the recommended screening technique in neonatal intensive care unit infants.  This study was conducted to evaluate the effect of aminoglycoside therapy on auditory brainstem evoked responses in term and preterm neonates.Methods: A cross-sectional case control study. Two groups of 26 term and 22 preterm neonates who received aminoglycosides, with no other known risk factors for ototoxicity, were compared with suitable matched control group of 10 neonates in each. ABER was done after at least 5 days of aminoglycoside therapy and results were compared to suitable matched controls.Results: Mean latency of wave I in term neonates at 90 dB and 60 dB and mean interwave latencies of I-V waves in preterm neonates at 30 dB was higher in study group and statistically significant. No statistically significant difference in any of ABER parameters was observed in any group, at all other intensities.Conclusions: Wave I latency was prolonged in study group of term neonates at two intensities which indicates effect of aminoglycoside therapy on distal portion of acoustic nerve. But as there were no such findings at other intensities in term study group and in preterm study group and moreover no other ABER abnormalities were observed, it was concluded that the aminoglycoside therapy has low potential for ototoxicity. Authors support the ABER screening for early detection of hearing abnormalities, and recommend study on larger group of neonates and meta-analysis for final conclusion for evidence-based recommendations to use aminoglycosides in neonates, in view of audiometric and neurological abnormalities.

Randomized Trial of Taurine Supplementation for Infants \g=le\1,300-Gram Birth Weight: Effect on Auditory Brainstem-Evoked Responses

PEDIATRICS ◽  
1989 ◽  
Vol 83 (3) ◽  
pp. 406-415
Author(s):  
Jon E. Tyson ◽  
Robert Lasky ◽  
Debbie Flood ◽  
Charles Mize ◽  
Tom Picone ◽  
...  
Keyword(s):  
Birth Weight ◽  
Randomized Trial ◽  
Behavioral Assessment ◽  
Caloric Intake ◽  
Auditory Brainstem ◽  
Evoked Responses ◽  
Taurine Supplementation ◽  
Auditory Evoked Responses ◽  
Postmenstrual Age ◽  
Auditory Brainstem Evoked Responses

Taurine may be important to the developing eye and brain of the small preterm infant. A blinded randomized trial was conducted to determine whether taurine supplementation of healthy infants of \g=le\1,300 g birth weight until their discharge from the hospital increases their growth rate, neurobehavioral development, electroretinographic development, or maturation of auditory brainstem-evoked responses. Infants were fed with Similac Special Care as desired, which was prepared to contain < 5 mg/L of taurine or 45 mg/L of taurine, a concentration similar to that of human milk. Infants who did not receive taurine supplementation (n = 19) and those who did (n = 18) were similar with respect to condition at study entry, caloric intake, and growth rates throughout the study, and electroretinographic findings and scores on the Brazelton Behavioral Assessment Scale at 37 weeks' postmenstrual age. Infants who received taurine supplementation had greater overall plasma taurine concentrations. The group receiving taurine supplementation also had more mature auditory-evoked responses at 37 weeks' postmenstrual age with a modest (0.2 to 0.5 ms) but consistent reduction (P < .05) in the interval between stimulus and response at two different stimulation rates. Although further study is needed, taurine intake appears to influence auditory system maturation of preterm infants.

The progress of adrenoleukodystrophy as revealed by auditory brainstem evoked responses and brainstem histology

1980 ◽  
Vol 228 (1) ◽  
pp. 17-27 ◽  
Author(s):  
Kimitaka Kaga ◽  
Yasuo Tokoro ◽  
Yoshisato Tanaka ◽  
Hiroshi Ushijima
Keyword(s):  
Auditory Brainstem ◽  
Evoked Responses ◽  
Auditory Brainstem Evoked Responses
Sign in / Sign up

Export Citation Format

Share Document